The Power of QTORIN™

High payload capacity optimizes potential for therapeutic activity: Accommodates high API concentrations, i.e. 3.9% rapamycin.

Delivery to dermis with limited systemic absorption: Delivers large molecular weight molecules to dermis while overcoming 500 Dalton Rule.

Favorable patient tolerability: Precisely selected composition of inactive excipients enables chronic dosing for lifelong genetic diseases.

Scalable cGMP process: Physical and chemical stability at room temperature providing for long-term shelf life.